Date

Wednesday, 16 June 2010

Location

European Medicines Agency, Amsterdam, the Netherlands

The meeting covered the following topics: revision of the mandate and rules of procedure of the PCWP; the interaction between the Agency and health technology assessment bodies; the interaction between the Agency and patient & consumer organisations; direct reporting of adverse events by patients.

Documents

Share this page